John A. Copland, PhD
Articles
May 8th 2012
Development of a Multidisciplinary, Multicampus Subspecialty Practice in Endocrine Cancers
Keith C. Bible, MD, PhD Robert C. Smallridge, MD John C. Morris, MD Julian R. Molina, MD Vera J. Suman, PhD John A. Copland, PhD Joseph Rubin, MD Michael E. Menefee, MD Kostandinos Sideras, MD
The development of subspecialty tumor groups for uncommon malignancies represents an effective approach to building experience, increasing patient volumes and referrals, and fostering development of increased therapeutic options and clinical trials for patients afflicted with otherwise historically neglected cancers.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: October 7th 2024 | Updated: November 22nd 2024
Managing Germline Mutations in Hereditary Breast Cancer Risk
